Document is current
Any future updates will be listed below
-
Authors
Chang, Tian-Gen https://orcid.org/0000-0003-1485-1992
Cao, Yingying
Sfreddo, Hannah J.
Dhruba, Saugato Rahman https://orcid.org/0000-0001-5947-6757
Lee, Se-Hoon https://orcid.org/0000-0002-9219-3350
Valero, Cristina https://orcid.org/0000-0003-3397-2888
Yoo, Seong-Keun https://orcid.org/0000-0002-8749-7050
Chowell, Diego
Morris, Luc G. T. https://orcid.org/0000-0002-4417-2280
Ruppin, Eytan https://orcid.org/0000-0002-7862-3940
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 24 April 2024
First Online: 3 June 2024
Competing interests
: E.R. is a cofounder of MedAware, Metabomed and Pangea Biomed (divested) and an unpaid member of Pangea Biomed’s scientific advisory board. L.G.T.M. is listed as an inventor on intellectual property owned by MSK related to the use of TMB in cancer immunotherapy, unrelated to this work. The other authors declare no competing interests.
